A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer.
Phase of Trial: Phase I
Latest Information Update: 12 Dec 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 12 Dec 2017 Results of pooled data from phase I/II assessing S-1 administered with intensity-modulated radiotherapy (IMRT) as adjuvant therapy for node-positive gastric cancer, were published in the British Journal of Cancer.
- 01 Sep 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Feb 2011 New trial record